Biotech

Genmab to Acquire Merus in $8B Deal, Adding Breakthrough Oncology Asset to Late-Stage Pipeline

$8B acquisition brings late-stage bispecific antibody petosemtamab into Genmab’s pipeline, accelerating shift to a wholly owned model with potential blockbuster launches by 2027.

N4 Pharma and SRI Advance Targeted RNA Delivery with Nuvec® Platform for Cancer Therapies

Collaboration with SRI demonstrates Nuvec®’s ability to selectively deliver RNA to cancer cells, advancing prospects for targeted, orally delivered RNA therapeutics.

Enhanced Genomics Secures $19M Series A Extension to Advance Therapeutics Pipeline

Biotech secures fresh investment to expand drug discovery in autoimmune and common diseases.

CN Bio Expands ADME Services with Computational Modeling Tools to Advance Drug Discovery

CN Bio has launched new PhysioMimix® computational modeling tools to strengthen ADME profiling, improve bioavailability predictions, and accelerate drug discovery workflows.

Domainex and Pharmacelera Partner to Advance AI-Driven Drug Discovery for Transmembrane Proteins

Collaboration integrates quantum mechanics-based modelling with cutting-edge experimental platforms to accelerate hit discovery for GPCRs and ion channels.

Qureight AI to Power Calluna’s Phase 2 IPF Study

AI-powered 3D lung imaging to accelerate assessment of CAL101, a first-in-class antibody targeting a key driver of fibrosis.